KBC Group’s NeoGenomics NEO Stock Holding History

KBC Group’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$77K	Sell	4,203 -2,354	-36%	-$38.8K	﹤0.01%	1554
2026 Q2	$96K	Hold	6,557	–	–	﹤0.01%	1446
2026 Q1	$49K	Hold	6,557	–	–	﹤0.01%	1663
2025 Q4	$77K	Hold	6,557	–	–	﹤0.01%	1454
2025 Q3	$51K	Hold	6,557	–	–	﹤0.01%	1643
2025 Q2	$48K	Hold	6,557	–	–	﹤0.01%	1620
2025 Q1	$62K	Hold	6,557	–	–	﹤0.01%	1723
2024 Q4	$108K	Buy	6,557 +2,027	+45%	+$31.5K	﹤0.01%	1503
2024 Q3	$67K	Buy	4,530 +1,127	+33%	+$17.6K	﹤0.01%	1556
2024 Q2	$47K	Hold	3,403	–	–	﹤0.01%	1653
2024 Q1	$53K	Hold	3,403	–	–	﹤0.01%	1526
2023 Q4	$55K	Sell	3,403 -394	-10%	-$6.45K	﹤0.01%	1460
2023 Q3	$47K	Sell	3,797 -6,289	-62%	-$93.5K	﹤0.01%	1496
2023 Q2	$162K	Hold	10,086	–	–	﹤0.01%	1004
2023 Q1	$176K	Sell	10,086 -767	-7%	-$10.9K	﹤0.01%	1017
2022 Q4	$100K	Hold	10,853	–	–	﹤0.01%	1198
2022 Q3	$93K	Hold	10,853	–	–	﹤0.01%	1219
2022 Q2	$88K	Buy	+10,853	New	+$104K	﹤0.01%	1277
2021 Q3	–	Sell	-1,045	Closed	-$47K	–	1320
2021 Q2	$47K	Hold	1,045	–	–	﹤0.01%	1236
2021 Q1	$50K	Hold	1,045	–	–	﹤0.01%	1243
2020 Q4	$56K	Buy	+1,045	New	+$47.2K	﹤0.01%	1207
2019 Q4	–	Sell	-29,097	Closed	-$556K	–	1531
2019 Q3	$556K	Hold	29,097	–	–	﹤0.01%	1048
2019 Q2	$638K	Hold	29,097	–	–	﹤0.01%	987
2019 Q1	$595K	Buy	+29,097	New	+$506K	﹤0.01%	1032

Other funds holding NEO

First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $77.1B AUM 11.99% 1-Year Est. Return

GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

KBC Group's NEO Position: Q3 2026 in Review

KBC Group reduced its NeoGenomics (NEO) stake by 36% in Q3 2026, selling an estimated $38.8K and leaving 4,203 shares worth $77K. The position accounts for ﹤0.01% of the portfolio, ranked #1554.

KBC Group first reported a position in NEO in Q1 2019 and has held it in 24 quarters since. The position peaked at $638K in Q2 2019. 188 funds tracked by Wall St. Rank hold NEO as of Q3 2026.

KBC Group held 4,203 shares of NeoGenomics worth $77K as of Q3 2026.
KBC Group sold 2,354 NeoGenomics shares in Q3 2026, an estimated $38.8K.
NeoGenomics made up ﹤0.01% of KBC Group's portfolio in Q3 2026, its #1554 holding.
KBC Group first reported a position in NeoGenomics in Q1 2019 and has held it in 24 quarters since.
KBC Group's NeoGenomics position peaked at $638K in Q2 2019.
188 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2026.

Based on KBC Group's 13F filing for Q3 2026, filed 22 Oct 2026.